HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
LHFPL5
LHFPL tetraspan subfamily member 5
Chromosome 6 Β· 6p21.31
NCBI Gene: 222662Ensembl: ENSG00000197753.11HGNC: HGNC:21253UniProt: Q8TAF8
22PubMed Papers
21Diseases
0Drugs
23Pathogenic Variants
FUNCTIONAL ROLE
Transporter
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingsensory perception of sounddetection of mechanical stimulus involved in sensory perceptionplasma membranehearing loss, autosomal recessivedeafnessnonsyndromic genetic hearing lossNon-syndromic genetic deafness
✦AI Summary

LHFPL5 is an auxiliary subunit of the mechanotransducer (MET) ion channel complex essential for auditory and vestibular function. It localizes to the tips of shorter stereocilia in cochlear hair cells, where it functionally couples the tip-link protein PCDH15 to the transduction channel pore 1. LHFPL5 physically interacts with and stabilizes the core channel protein TMC1, with mutations disrupting this binding and destabilizing TMC1 expression 2. The PCDH15-LHFPL5 complex forms a 2-fold symmetric assembly where LHFPL5 stabilizes PCDH15 transmembrane helices and transmits stereociliary deflection forces to open the MET channel 1. LHFPL5 works alongside other auxiliary proteins including TMIE, CIB2, and TOMT to maintain channel complex positioning at the tip link 3. Biallelic loss-of-function variants in LHFPL5 cause autosomal recessive nonsyndromic hearing impairment (DFNB67), with identified mutations including frameshift deletions, missense variants, and splice site alterations 45. LHFPL5 dysfunction also causes bilateral vestibular dysfunction alongside deafness 6, indicating its critical role in both auditory and vestibular mechanotransduction.

Sources cited
1
LHFPL5 forms extensive interactions with PCDH15 transmembrane helices in a 2-fold symmetric complex and stabilizes overall assembly
PMID: 30070639
2
LHFPL5 physically interacts with and stabilizes TMC1, and deafness mutation D572N disrupts LHFPL5 binding destabilizing TMC1 expression
PMID: 33168709
3
LHFPL5 is part of TMC1-driven mechanotransduction channel complex at stereocilia tip links and LOXHD1 helps maintain this localization
PMID: 39256406
4
LHFPL5 gene variants including missense and splice site mutations cause autosomal recessive nonsyndromic hearing impairment (DFNB67)
PMID: 30177809
5
LHFPL5 mutations identified as causative in families with hearing loss, expanding mutation spectrum
PMID: 28281779
6
LHFPL5 splice site variants cause hearing loss and vestibular dysfunction, indicating role in both auditory and vestibular mechanotransduction
PMID: 41400044
Disease Associationsβ“˜21
hearing loss, autosomal recessiveOpen Targets
0.71Strong
deafnessOpen Targets
0.61Moderate
nonsyndromic genetic hearing lossOpen Targets
0.40Weak
Non-syndromic genetic deafnessOpen Targets
0.38Weak
autosomal recessive non-syndromic intellectual disabilityOpen Targets
0.34Weak
Hearing impairmentOpen Targets
0.30Weak
Abnormality of the earOpen Targets
0.27Weak
ear malformationOpen Targets
0.27Weak
Rare genetic deafnessOpen Targets
0.27Weak
genetic disorderOpen Targets
0.19Weak
autosomal dominant nonsyndromic hearing lossOpen Targets
0.14Weak
type 1 diabetes mellitusOpen Targets
0.14Weak
autosomal recessive nonsyndromic hearing loss 9Open Targets
0.07Suggestive
autismOpen Targets
0.07Suggestive
autism spectrum disorderOpen Targets
0.05Suggestive
thyroid diseaseOpen Targets
0.05Suggestive
Autosomal recessive cerebellar ataxia - blindness - deafnessOpen Targets
0.05Suggestive
peroxisome biogenesis disorder 4BOpen Targets
0.05Suggestive
intellectual disability, autosomal dominant 50Open Targets
0.04Suggestive
Autosomal recessive spastic paraplegia type 44Open Targets
0.04Suggestive
Deafness, autosomal recessive, 67UniProt
Pathogenic Variants23
NM_182548.4(LHFPL5):c.395G>A (p.Trp132Ter)Pathogenic
not provided|LHFPL5-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 132
NM_182548.4(LHFPL5):c.472C>T (p.Arg158Trp)Pathogenic
not specified|Deafness|not provided|Autosomal recessive nonsyndromic hearing loss 67
β˜…β˜…β˜†β˜†2025β†’ Residue 158
NM_182548.4(LHFPL5):c.1A>G (p.Met1Val)Pathogenic
Autosomal recessive nonsyndromic hearing loss 67|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 1
NM_182548.4(LHFPL5):c.649G>A (p.Glu217Lys)Likely pathogenic
Monogenic hearing loss
β˜…β˜†β˜†β˜†2025β†’ Residue 217
NM_182548.4(LHFPL5):c.396G>A (p.Trp132Ter)Pathogenic
Autosomal recessive nonsyndromic hearing loss 67
β˜…β˜†β˜†β˜†2025β†’ Residue 132
NM_182548.4(LHFPL5):c.650-2A>GPathogenic
Autosomal recessive nonsyndromic hearing loss 67
β˜…β˜†β˜†β˜†2025
NM_182548.4(LHFPL5):c.200A>G (p.Tyr67Cys)Likely pathogenic
Autosomal recessive nonsyndromic hearing loss 67
β˜…β˜†β˜†β˜†2025β†’ Residue 67
NM_182548.4(LHFPL5):c.53A>G (p.Tyr18Cys)Likely pathogenic
Autosomal recessive nonsyndromic hearing loss 67
β˜…β˜†β˜†β˜†2025β†’ Residue 18
NM_182548.4(LHFPL5):c.222del (p.Ser75fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 75
NM_182548.4(LHFPL5):c.300del (p.Phe100fs)Likely pathogenic
Autosomal recessive nonsyndromic hearing loss 67
β˜…β˜†β˜†β˜†2024β†’ Residue 100
NM_182548.4(LHFPL5):c.526C>T (p.Arg176Cys)Likely pathogenic
Hearing loss, autosomal recessive
β˜…β˜†β˜†β˜†2024β†’ Residue 176
NM_182548.4(LHFPL5):c.219_223del (p.Ser74fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 74
NM_182548.4(LHFPL5):c.649+1delLikely pathogenic
Autosomal recessive nonsyndromic hearing loss 67|Ear malformation
β˜…β˜†β˜†β˜†2021
NM_182548.4(LHFPL5):c.504C>G (p.Tyr168Ter)Likely pathogenic
Hearing impairment
β˜…β˜†β˜†β˜†2021β†’ Residue 168
NM_182548.4(LHFPL5):c.*16+1G>APathogenic
Autosomal recessive nonsyndromic hearing loss 67
β˜…β˜†β˜†β˜†2020
NM_182548.4(LHFPL5):c.250del (p.Pro83_Leu84insTer)Pathogenic
Autosomal recessive nonsyndromic hearing loss 67|Hearing loss, autosomal recessive
β˜…β˜†β˜†β˜†2020β†’ Residue 83
NM_182548.4(LHFPL5):c.89dup (p.Thr31fs)Likely pathogenic
Rare genetic deafness
β˜…β˜†β˜†β˜†2018β†’ Residue 31
NM_182548.4(LHFPL5):c.575T>C (p.Leu192Pro)Pathogenic
Autosomal recessive non-syndromic intellectual disability;Autosomal recessive nonsyndromic hearing loss 67
β˜…β˜†β˜†β˜†2017β†’ Residue 192
NM_182548.4(LHFPL5):c.380A>G (p.Tyr127Cys)Likely pathogenic
Autosomal recessive nonsyndromic hearing loss 67
β˜…β˜†β˜†β˜†β†’ Residue 127
NM_182548.4(LHFPL5):c.34A>T (p.Lys12Ter)Likely pathogenic
Autosomal recessive nonsyndromic hearing loss 67
β˜…β˜†β˜†β˜†β†’ Residue 12
View on ClinVar β†—
Related Genes
TMIEProtein interaction95%COL11A2Protein interaction86%GGT7Protein interaction79%MYO7AProtein interaction79%USH1CProtein interaction79%CIB2Protein interaction79%
Tissue Expression6 tissues
Brain
100%
Liver
7%
Ovary
6%
Lung
6%
Heart
0%
Bone Marrow
0%
Gene Interaction Network
Click a node to explore
LHFPL5TMIECOL11A2GGT7MYO7AUSH1CCIB2
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q8TAF8
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.98LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.60 [0.39–0.98]
RankingsWhere LHFPL5 stands among ~20K protein-coding genes
  • #13,686of 20,598
    Most Researched22
  • #2,079of 5,498
    Most Pathogenic Variants23
  • #9,294of 17,882
    Most Constrained (LOEUF)0.98
Genes detectedLHFPL5
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Molecular Analysis of Twelve Pakistani Families with Nonsyndromic or Syndromic Hearing Loss.
PMID: 28281779
Genet Test Mol Biomarkers Β· 2017
1.00
2
LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.
PMID: 39256406
Nat Commun Β· 2024
0.90
3
[Advances in research on function of
PMID: 40419344
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi Β· 2025
0.80
4
Deafness mutation D572N of TMC1 destabilizes TMC1 expression by disrupting LHFPL5 binding.
PMID: 33168709
Proc Natl Acad Sci U S A Β· 2020
0.70
5
Structure of mouse protocadherin 15 of the stereocilia tip link in complex with LHFPL5.
PMID: 30070639
Elife Β· 2018
0.60